Aptahem AB
556970-5782ActiveBiotech company developing RNA therapeutics for acute inflammatory diseases like sepsis.
Biotechnology Companyaptahem.com
Yleiskatsaus
- 1–4
- Työntekijät
- ≤1t SEK
- Liikevaihto
- 2014
- Perustettu
Avainpäättäjät
Mikael Lindstam
CEO
Kuvaus
Aptahem is a specialized biotechnology company focused on developing novel RNA-based pharmaceuticals. Their primary mission is to create disruptive treatments for acute, life-threatening inflammatory diseases, such as sepsis. The company's lead drug candidate, Apta-1, is currently progressing throug...
Tunnisteet
B2BPharmaceuticals
Avainsanat
Aptamers